SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

John Hancock Funds II – ‘N-CEN’ for 7/31/22 – ‘INTERNAL CONTROL RPT’

On:  Tuesday, 10/4/22, at 3:21pm ET   ·   Effective:  10/4/22   ·   For:  7/31/22   ·   Accession #:  1145549-22-60893   ·   File #:  811-21779

Previous ‘N-CEN’:  ‘N-CEN’ on 3/11/22 for 12/31/21   ·   Next:  ‘N-CEN’ on 11/14/22 for 8/31/22   ·   Latest:  ‘N-CEN’ on 3/14/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/04/22  John Hancock Funds II             N-CEN       7/31/22    4:341K                                   DFIN So… FundSuiteArc/FAAbsolute Return Currency Fund Class A (JCUAX) — Class C (JCUCX) — Class I (JCUIX) — Class NAVClass R4 (JARRX) — Class R6 (JCURX)Fundamental All Cap Core Fund Class A (JFCAX) — Class C (JFCCX) — Class I (JFCIX) — Class R2 (JFACX) — Class R4 (JFARX) — Class R5Class R6 (JFAIX)Multi-Asset Absolute Return Fund Class A (JHAAX) — Class C (JHACX) — Class I (JHAIX) — Class NAVClass R2 (JHARX) — Class R4Class R5Class R6 (JHASX)

Annual Report by an Investment Company   —   Form N-CEN   —   ICA’40

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: N-CEN       Annual Report by an Investment Company --           HTML    324K 
                primary_doc.xml/4.4                                              
 4: EXEMPT ORDER INFO  Info Pursuant to an SEC Exemption Order      HTML      6K 
 2: INTERNAL CONTROL RPT  Accountant's Report re: Internal          HTML      8K 
                Controls                                                         
 3: INTERNAL CONTROL RPT  Accountant's Report re: Internal          HTML      8K 
                Controls                                                         


‘INTERNAL CONTROL RPT’   —   Accountant’s Report re: Internal Controls


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  PDFtoHTML Conversion Output  

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of John Hancock Funds II and Shareholders of John Hancock Absolute Return Currency Fund

In planning and performing our audit of the financial statements of John Hancock Absolute Return Currency Fund (one of the funds constituting John Hancock Funds II, hereafter collectively referred to as the "Fund") as of and for the year ended July 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of July 31, 2022.

This report is intended solely for the information and use of the Board of Trustees of John Hancock Funds II and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
September 23, 2022


PricewaterhouseCoopers LLP, 101 Seaport Boulevard, Suite 500, Boston, MA 02210
T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘N-CEN’ Filing    Date    Other Filings
Filed on / Effective on:10/4/2240-17F2
9/23/22
For Period end:7/31/22N-CSR,  NPORT-P
 List all Filings 
Top
Filing Submission 0001145549-22-060893   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 2:53:19.1pm ET